These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36094217)

  • 21. Molecular characteristics of community-acquired methicillin-resistant Staphylococcus aureus in Hokkaido, northern main island of Japan: identification of sequence types 6 and 59 Panton-Valentine leucocidin-positive community-acquired methicillin-resistant Staphylococcus aureus.
    Kawaguchiya M; Urushibara N; Kuwahara O; Ito M; Mise K; Kobayashi N
    Microb Drug Resist; 2011 Jun; 17(2):241-50. PubMed ID: 21395449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid.
    Mendes RE; Sader HS; Deshpande LM; Diep BA; Chambers HF; Jones RN
    J Clin Microbiol; 2010 Feb; 48(2):568-74. PubMed ID: 19940054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular characteristics and virulence factors in methicillin-susceptible, resistant, and heterogeneous vancomycin-intermediate Staphylococcus aureus from central-southern China.
    Liu C; Chen ZJ; Sun Z; Feng X; Zou M; Cao W; Wang S; Zeng J; Wang Y; Sun M
    J Microbiol Immunol Infect; 2015 Oct; 48(5):490-6. PubMed ID: 24767415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular epidemiology and clinical characteristics of hetero-resistant vancomycin intermediate Staphylococcus aureus bacteremia in a Taiwan Medical Center.
    Lin SY; Chen TC; Chen FJ; Chen YH; Lin YI; Siu LK; Lu PL
    J Microbiol Immunol Infect; 2012 Dec; 45(6):435-41. PubMed ID: 22749725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Characterization of Methicillin and Vancomycin Resistant
    Jahanshahi A; Zeighami H; Haghi F
    Microb Drug Resist; 2018 Dec; 24(10):1529-1536. PubMed ID: 29883257
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia.
    Choi EY; Huh JW; Lim CM; Koh Y; Kim SH; Choi SH; Kim YS; Kim MN; Hong SB
    Intensive Care Med; 2011 Apr; 37(4):639-47. PubMed ID: 21253703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus aureus from Bloodstream Infections in a Brazilian Teaching Hospital.
    da Costa TM; Morgado PG; Cavalcante FS; Damasco AP; Nouér SA; Dos Santos KR
    PLoS One; 2016; 11(8):e0160506. PubMed ID: 27575698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Prevalence of Vancomycin-Intermediate Staphylococcus aureus and Heterogeneous VISA Among Methicillin-Resistant Strains Isolated from Pediatric Population in a Turkish University Hospital.
    Mirza HC; Sancak B; Gür D
    Microb Drug Resist; 2015 Oct; 21(5):537-44. PubMed ID: 25919019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus.
    Hafer C; Lin Y; Kornblum J; Lowy FD; Uhlemann AC
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5845-51. PubMed ID: 22948864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Microbiological Characteristics of qacA/B-Positive Methicillin-Resistant Staphylococcus aureus Isolates in a Surgical Intensive Care Unit.
    Cho OH; Park KH; Song JY; Hong JM; Kim T; Hong SI; Kim S; Bae IG
    Microb Drug Resist; 2018 Apr; 24(3):283-289. PubMed ID: 28799881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.
    Martirosov DM; Bidell MR; Pai MP; Scheetz MH; Rosenkranz SL; Faragon C; Malik M; Mendes RE; Jones RN; McNutt LA; Lodise TP
    BMC Infect Dis; 2017 Aug; 17(1):534. PubMed ID: 28764660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular analysis of immune evasion cluster (IEC) genes and intercellular adhesion gene cluster (ICA) among methicillin-resistant and methicillin-sensitive isolates of
    Ahmadrajabi R; Layegh-Khavidaki S; Kalantar-Neyestanaki D; Fasihi Y
    J Prev Med Hyg; 2017 Dec; 58(4):E308-E314. PubMed ID: 29707662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methicillin-resistant and vancomycin-intermediate Staphylococcus aureus colonizing patients and intensive care unit environment: virulence profile and genetic variability.
    Veloso JO; Lamaro-Cardoso J; Neves LS; Borges LFA; Pires CH; Lamaro L; Guerreiro TC; Ferreira EMA; André MCP
    APMIS; 2019 Nov; 127(11):717-726. PubMed ID: 31407405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methicillin-Resistant Staphylococcus aureus Sequence Type (ST) 5 Isolates from Health Care and Agricultural Sources Adhere Equivalently to Human Keratinocytes.
    Hau SJ; Kellner S; Eberle KC; Waack U; Brockmeier SL; Haan JS; Davies PR; Frana T; Nicholson TL
    Appl Environ Microbiol; 2018 Jan; 84(2):. PubMed ID: 29101193
    [No Abstract]   [Full Text] [Related]  

  • 36. Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA.
    Horne KC; Howden BP; Grabsch EA; Graham M; Ward PB; Xie S; Mayall BC; Johnson PD; Grayson ML
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3447-52. PubMed ID: 19506056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association of molecular typing, vancomycin MIC, and clinical outcome for patients with methicillin-resistant Staphylococcus aureus infections.
    Chen CP; Liu MF; Lin CF; Lin SP; Shi ZY
    J Microbiol Immunol Infect; 2017 Oct; 50(5):619-626. PubMed ID: 26497450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey.
    Sancak B; Yagci S; Gür D; Gülay Z; Ogunc D; Söyletir G; Yalcin AN; Dündar DO; Topçu AW; Aksit F; Usluer G; Ozakin C; Akalin H; Hayran M; Korten V
    BMC Infect Dis; 2013 Dec; 13():583. PubMed ID: 24325260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in
    Choi S; Moon SM; Park SJ; Lee SC; Jung KH; Sung HS; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
    Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
    Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.